NCT01990885View on ClinicalTrials.gov

Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Celiac Disease

Interventions

DRUG

BL-7010

DRUG

Placebo

Trial Locations (2)

Unknown

FinnMedi Clinical Trial Center, Tampere

CRST Clinical Research Services, Turku

Sponsors

Lead Sponsor

BioLineRx, Ltd.

All Listed Sponsors

lead

BioLineRx, Ltd.

INDUSTRY

NCT01990885 - Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. | Biotech Hunter | Biotech Hunter